Literature DB >> 29543435

Aβ42 Protofibrils Interact with and Are Trafficked through Microglial-Derived Microvesicles.

Lisa K Gouwens1, Mudar S Ismail1, Victoria A Rogers1, Nathan T Zeller1, Evan C Garrad1, Fatima S Amtashar1, Nyasha J Makoni1, David C Osborn1, Michael R Nichols1.   

Abstract

Microvesicles (MVs) and exosomes comprise a class of cell-secreted particles termed extracellular vesicles (EVs). These cargo-holding vesicles mediate cell-to-cell communication and have recently been implicated in neurodegenerative diseases such as Alzheimer's disease (AD). The two types of EVs are distinguished by the mechanism of cell release and their size, with the smaller exosomes and the larger MVs ranging from 30 to 100 nm and 100 nm to 1 μm in diameter, respectively. MV numbers are increased in AD and appear to interact with amyloid-β peptide (Aβ), the primary protein component of the neuritic plaques in the AD brain. Because microglial cells play such an important role in AD-linked neuroinflammation, we sought to characterize MVs shed from microglial cells, better understand MV interactions with Aβ, and determine whether internalized Aβ may be incorporated into secreted MVs. Multiple strategies were used to characterize MVs shed from BV-2 microglia after ATP stimulation. Confocal images of isolated MVs bound to fluorescently labeled annexin-V via externalized phosphatidylserine revealed a polydisperse population of small spherical structures. Dynamic light scattering measurements yielded MV diameters ranging from 150 to 600 nm. Electron microscopy of resin-embedded MVs cut into thin slices showed well-defined uranyl acetate-stained ring-like structures in a similar diameter range. The use of a fluorescently labeled membrane insertion probe, NBD C6-HPC, effectively tracked MVs in binding experiments, and an Aβ ELISA confirmed a strong interaction between MVs and Aβ protofibrils but not Aβ monomers. Despite the lesser monomer interaction, MVs had an inhibitory effect on monomer aggregation. Primary microglia rapidly internalized Aβ protofibrils, and subsequent stimulation of the microglia with ATP resulted in the release of MVs containing the internalized Aβ protofibrils. The role of MVs in neurodegeneration and inflammation is an emerging area, and further knowledge of MV interaction with Aβ may shed light on extracellular spread and influence on neurotoxicity and neuroinflammation.

Entities:  

Keywords:  Amyloid-beta; microglia; microvesicles; protofibrils

Mesh:

Substances:

Year:  2018        PMID: 29543435     DOI: 10.1021/acschemneuro.8b00029

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  13 in total

Review 1.  Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease.

Authors:  Jean-Christophe Delpech; Shawn Herron; Mina B Botros; Tsuneya Ikezu
Journal:  Trends Neurosci       Date:  2019-03-26       Impact factor: 13.837

2.  Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males.

Authors:  Ursula S Sandau; Trevor J McFarland; Sierra J Smith; Douglas R Galasko; Joseph F Quinn; Julie A Saugstad
Journal:  Front Cell Dev Biol       Date:  2022-04-27

Review 3.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

4.  Roles of microglial membranes in Alzheimer's disease.

Authors:  Jae-Won Shin; James C Lee
Journal:  Curr Top Membr       Date:  2020-09-11       Impact factor: 3.049

5.  Microglia-Derived Microvesicles Affect Microglia Phenotype in Glioma.

Authors:  Alfonso Grimaldi; Carmela Serpe; Giuseppina Chece; Valentina Nigro; Angelo Sarra; Barbara Ruzicka; Michela Relucenti; Giuseppe Familiari; Giancarlo Ruocco; Giuseppe Rubens Pascucci; Francesca Guerrieri; Cristina Limatola; Myriam Catalano
Journal:  Front Cell Neurosci       Date:  2019-02-22       Impact factor: 5.505

6.  Increased Microglial Exosomal miR-124-3p Alleviates Neurodegeneration and Improves Cognitive Outcome after rmTBI.

Authors:  Xintong Ge; Mengtian Guo; Tianpeng Hu; Wenzhu Li; Shan Huang; Zhenyu Yin; Ying Li; Fanglian Chen; Luoyun Zhu; Chunsheng Kang; Rongcai Jiang; Ping Lei; Jianning Zhang
Journal:  Mol Ther       Date:  2019-11-27       Impact factor: 11.454

7.  Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.

Authors:  Yingyue Zhou; Wilbur M Song; Prabhakar S Andhey; Amanda Swain; Tyler Levy; Kelly R Miller; Pietro L Poliani; Manuela Cominelli; Shikha Grover; Susan Gilfillan; Marina Cella; Tyler K Ulland; Konstantin Zaitsev; Akinori Miyashita; Takeshi Ikeuchi; Makoto Sainouchi; Akiyoshi Kakita; David A Bennett; Julie A Schneider; Michael R Nichols; Sean A Beausoleil; Jason D Ulrich; David M Holtzman; Maxim N Artyomov; Marco Colonna
Journal:  Nat Med       Date:  2020-01-13       Impact factor: 53.440

Review 8.  Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration.

Authors:  Ricardo Quiroz-Baez; Karina Hernández-Ortega; Eduardo Martínez-Martínez
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

Review 9.  The Amyloid-β Pathway in Alzheimer's Disease.

Authors:  Harald Hampel; John Hardy; Kaj Blennow; Christopher Chen; George Perry; Seung Hyun Kim; Victor L Villemagne; Paul Aisen; Michele Vendruscolo; Takeshi Iwatsubo; Colin L Masters; Min Cho; Lars Lannfelt; Jeffrey L Cummings; Andrea Vergallo
Journal:  Mol Psychiatry       Date:  2021-08-30       Impact factor: 15.992

Review 10.  Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes.

Authors:  Michael R Duggan; Anne Lu; Thomas C Foster; Mathieu Wimmer; Vinay Parikh
Journal:  Front Aging Neurosci       Date:  2022-03-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.